{"entity":{"type":"insider","cik":"0001652023","url":"/insider/0001652023","json_url":"/insider/0001652023.json","name":"Reverberi Gian Piero","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2019-01-04","last":"2020-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Reverberi Gian Piero","source":"filing","n_filings":4,"first_seen":"2019-01-04","last_seen":"2020-03-04"}],"transactions":[{"id":2727765,"accession":"0001209191-20-016208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016208","line_url":"/filing/0001209191-20-016208#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652023","owner_name":"Reverberi Gian Piero","owner_display_name":"Reverberi Gian Piero","owner_url":"/insider/0001652023","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450.0,"shares_display":"1,450","price_per_share":10.176,"price_display":"10.18","price_state":"stated","total_value":14755.2,"total_display":"14,755.20","total_whole":"14,755","shares_owned_after":165384.0,"shares_owned_after_display":"165,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2065787,"accession":"0001209191-20-002032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002032","line_url":"/filing/0001209191-20-002032#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652023","owner_name":"Reverberi Gian Piero","owner_display_name":"Reverberi Gian Piero","owner_url":"/insider/0001652023","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1155.0,"shares_display":"1,155","price_per_share":16.0612,"price_display":"16.06","price_state":"stated","total_value":18550.686,"total_display":"18,550.69","total_whole":"18,551","shares_owned_after":166834.0,"shares_owned_after_display":"166,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":8753743,"accession":"0001209191-19-015749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015749","line_url":"/filing/0001209191-19-015749#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652023","owner_name":"Reverberi Gian Piero","owner_display_name":"Reverberi Gian Piero","owner_url":"/insider/0001652023","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":443.0,"shares_display":"443","price_per_share":19.916,"price_display":"19.92","price_state":"stated","total_value":8822.788,"total_display":"8,822.79","total_whole":"8,823","shares_owned_after":167989.0,"shares_owned_after_display":"167,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-04","scope":"insider"},{"id":8753739,"accession":"0001209191-19-015749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015749","line_url":"/filing/0001209191-19-015749#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652023","owner_name":"Reverberi Gian Piero","owner_display_name":"Reverberi Gian Piero","owner_url":"/insider/0001652023","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":438.0,"shares_display":"438","price_per_share":20.165,"price_display":"20.16","price_state":"stated","total_value":8832.27,"total_display":"8,832.27","total_whole":"8,832","shares_owned_after":168432.0,"shares_owned_after_display":"168,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8003140,"accession":"0001209191-19-002004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-002004","line_url":"/filing/0001209191-19-002004","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001652023","owner_name":"Reverberi Gian Piero","owner_display_name":"Reverberi Gian Piero","owner_url":"/insider/0001652023","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1130.0,"shares_display":"1,130","price_per_share":26.586150442477877,"price_display":"26.59","price_state":"stated","total_value":30042.35,"total_display":"30,042.35","total_whole":"30,042","shares_owned_after":139400.0,"shares_owned_after_display":"139,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP & Chief Commercial Officer)","n_filings":4,"first_seen":"2019-01-04","last_seen":"2020-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652023","retrieved_at":"2026-08-24T05:37:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}